Navigation Links
Morphotek®, Inc. Receives Beacon Award From CancerCare
Date:4/6/2011

EXTON, Pa., April 6, 2011 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it was recently awarded the Beacon Award from CancerCare, a national support services organization for people affected by cancer, for its support of CancerCare's educational programs for people facing lung and ovarian cancers.  The two organizations have been working together to help patients and their families become aware of options available to help treat and manage these diseases.  The award was presented at CancerCare's 28th Annual "Partnership in Hope" Dinner in New York City.

"We are honored to be recognized by CancerCare for our team's efforts in working closely with advocacy groups and patients to better understand how to better meet the clinical and emotional needs of patients with cancer," said Nicholas Nicolaides, President and Chief Executive Officer at Morphotek. "Our efforts reflect the philosophy of our team, instilled by our parent company, Eisai, whose human healthcare (hhc) mission is to pursue drug development that satisfies unmet medical needs in a manner that improves the well-being of patients worldwide. This award endorses our efforts in pursuing this mission."

"Morphotek's commitment to innovation cannot be understated," said CancerCare's Chief Executive Officer, Helen H. Miller. "We are grateful to Morphotek for their continued support of CancerCare's free educational programs, as it is vital for people affected by cancer to have access to the most up-to-date information about their diagnosis and its treatment options."

As part of its human healthcare (hhc) mission, the company seeks to proactively learn about the underlying causes of diseases and available approved/experimental therapies. Additionally, the company seeks to learn the patients' thoughts about their disease and treatments by working with key opinion leade
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Morphotek®, Inc. Announces an Agreement with Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues
2. Cellectis Receives Payment for License to Homologous Recombination Patents
3. China-Biotics Receives First U.S. Sales Order
4. BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
5. Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer
6. ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardts Disease
7. Mylans Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg
8. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
9. EMD Serono Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application
10. Rensselaer professor Daniel Lewis receives NSF CAREER Award
11. Pacific Shore Holdings, Inc. Receives Symbol Change Approval From FINRA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... , Aug. 18, 2014 BioElectronics ... advanced consumer medical devices said that its ... interviewed by CEOLIVE.TV as part of its ... interview is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... explains to investors the unique advantages of ...
(Date:8/18/2014)... HIV Infection Drug Market and Pipeline Insight is a ... infection and the number of deaths due to AIDS has ... the globe. It has been estimated that the death rate ... with the rates for children being even much lower. A ... has been the improved access to antiretroviral drugs and therapy ...
(Date:8/18/2014)... 2014 TNI BioTech, Inc. (OTC-BB: TNIB) ("we" ... and marketing of innovative therapies for autoimmune diseases in ... a second notice of TNI BioTech,s annual meeting of ... Noreen Griffin , founder and CEO of TNI ... participation in the Annual Meeting. On behalf of our ...
(Date:8/18/2014)... , 18. August 2014 Vier ... eine internationale klinische Studie auf, in der ... Linse soll das Sehvermögen bei allen Entfernungen ... Operation möglicherweise keine Lese- oder Gleitsichtbrille mehr ... Namen FluidVision Accommodating Intraocular Lens ...
Breaking Biology Technology:BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... 5 Compendia Bioscience today,announced that it ... (NYSE: GSK ) for Oncomine(TM) Enterprise ... Oncomine.,Oncomine Enterprise Edition builds upon the features ... the ability to securely,view proprietary gene expression ...
... American Oriental,Bioengineering (NYSE: AOB ) announced ... offering. The decision to cancel its,convertible preferred stock ... market conditions resulting in terms that were not ... Statements made in this press release are ...
... Exelixis,Inc. (Nasdaq: EXEL ) announced earlier today ... Deerfield Management. The arrangement will,be discussed by Exelixis management ... ET today, Thursday, June 5. To listen to a ... Investors at, http://www.exelixis.com ., A replay of the ...
Cached Biology Technology:GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience 2
(Date:8/19/2014)... treat pain, but its effect on pain following ... recent study reported on the Neural Regeneration ... models of an avulsion injury to the left ... pain) were given electroacupuncture stimulation at bilateral Quchi ... After electroacupuncture therapy, chronic neuropathic pain in the ...
(Date:8/19/2014)... forms, they have not been widely used due to ... the University of Surrey and Trinity College Dublin have ... graphene, to create a flexible sensor that is sensitive ... , Once treated, the rubber bands remain highly ... imparts an electromechanical response on movement the team ...
(Date:8/18/2014)... , August 19, 2014 ... biometric authentication in smart devices  Trustonic, ... for smart devices, and Fingerprint Cards AB (FPC) ... of FIDO Ready™ secure biometric authentication on connected ... touch fingerprint sensors (FPC1020, FPC1021 and FPC1150) and ...
Breaking Biology News(10 mins):Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 2Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 4
... OAK RIDGE, Tenn., Oct. 4, 2010 -- Supercomputer ... are helping scientists unravel how nucleic acids could have contributed ... team led by Jeremy Smith, who directs ORNL,s Center for ... Tennessee, used molecular dynamics simulation to probe an organic chemical ...
... Rochelle, NY, October 4, 2010 Briefings in Palliative, Hospice, ... Journal of Palliative Medicine published by Mary ... announce a collaboration with The Institute for Palliative Medicine,s ... to create a new monthly feature for the e-newsletter. ...
... Can diet affect our children,s long-term mental and ... number of international leading experts on child nutrition next ... organized within the 7th Framework Programme Nutrimenthe, entitled "Effect ... The European Project Nutimenthe -funded by the European Commission ...
Cached Biology News:Powerful supercomputer peers into the origin of life 2PAL-MED CONNECT partners with Briefings in Palliative, Hospice, and Pain Medicine & Management 2Experts will meet to discuss how diet affects behavioral development of children 2
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
... state of the Art GLP facility ... dual 38,000 L fermentation. Coordinated ... production. Aseptic operation capable of ... and Continuous Modes. Hosts include: ...
Request Info...
Immunogen: VDAC3 Protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: